| Preetham Reddy Muskula, MD | |
|
2608 Mcdonald Rd, Tyler, TX 75701-5934 | |
| (903) 595-5514 | |
| (903) 262-3715 |
| Full Name | Preetham Reddy Muskula |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 2608 Mcdonald Rd, Tyler, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003104605 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
| Ut Health East Texas Henderson Hospital | Henderson, TX | Hospital |
| Ut Health East Texas Jacksonville Hospital | Jacksonville, TX | Hospital |
| Ut Health East Texas Pittsburg Hospital | Pittsburg, TX | Hospital |
| Ut Health East Texas Quitman Hospital | Quitman, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Etmc Physician Group, Inc. | 4486915600 | 276 |
News Archive
A Fox poll finds more than half of voters are inclined to support candidates that oppose the health overhaul, but Democrats say that other polls show a band of independent voters who may not like the law but don't want it repealed.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has completed enrollment of patients for its multiple indication diagnostic clinical trials.
Cardiovascular disease costs the UK economy £29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.
› Verified 3 days ago
| Entity Name | Laredo Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659619260 PECOS PAC ID: 1355582461 Enrollment ID: O20130731000645 |
News Archive
A Fox poll finds more than half of voters are inclined to support candidates that oppose the health overhaul, but Democrats say that other polls show a band of independent voters who may not like the law but don't want it repealed.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has completed enrollment of patients for its multiple indication diagnostic clinical trials.
Cardiovascular disease costs the UK economy £29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.
› Verified 3 days ago
| Entity Name | Etmc Physician Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609382662 PECOS PAC ID: 4486915600 Enrollment ID: O20180305002106 |
News Archive
A Fox poll finds more than half of voters are inclined to support candidates that oppose the health overhaul, but Democrats say that other polls show a band of independent voters who may not like the law but don't want it repealed.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has completed enrollment of patients for its multiple indication diagnostic clinical trials.
Cardiovascular disease costs the UK economy £29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Preetham Reddy Muskula, MD 2608 Mcdonald Rd, Tyler, TX 75701-5934 Ph: (903) 595-5514 | Preetham Reddy Muskula, MD 2608 Mcdonald Rd, Tyler, TX 75701-5934 Ph: (903) 595-5514 |
News Archive
A Fox poll finds more than half of voters are inclined to support candidates that oppose the health overhaul, but Democrats say that other polls show a band of independent voters who may not like the law but don't want it repealed.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it has completed enrollment of patients for its multiple indication diagnostic clinical trials.
Cardiovascular disease costs the UK economy £29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.
› Verified 3 days ago
Ifeatu Uchenna Oti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Medical Dr, Tyler, TX 75701 Phone: 903-595-5486 Fax: 903-595-5128 | |
Dr. Varalaxmi Bhavani Nannaka, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 912 S Fleishel Ave, Tyler, TX 75701 Phone: 903-592-6901 | |
David A Brickey, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 E Dawson St, Tyler, TX 75701 Phone: 903-525-1914 | |
Randy Craig Randall, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1783 Troup Highway, Tyler, TX 75701 Phone: 903-595-2283 Fax: 903-595-1063 | |
Nabeel K Ahmed, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Medical Dr, Tyler, TX 75701 Phone: 903-595-5486 Fax: 903-595-5128 | |
Dr. Amanda Nicole Long, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 S Fleishel Ave, Ste 327, Tyler, TX 75701 Phone: 903-510-1173 |